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Abstract 
Herein we report the synthesis and investigation of two novel tris-cyclometalated iridium 
complexes derived from [Ir(ppy)3] and bearing an aminoalkyl substituent on one of the 2-
phenylpyridine ligands. These complexes differ in the number of the alkyl substituents of 
the aminoalkyl group. Specifically, the complexes reported herein contain one (1) and two 
(2) 2-hydroxy ethyl groups on the nitrogen atom. Both complexes retain the good 
photophysical properties reported for earlier versions of this group of tris-cyclometalated 
iridium complexes. However, the differences in the substitution results in changes in the 
responsive photoluminescence behavior in aqueous solutions. Live cell microscopy 
experiments revealed that complexes can localize in NIH-3T3 cells. Finally, it has been 
observed that the complex containing two 2-hydroxy ethyl groups is less cytotoxic than 
the it’s mono-substituted counterpart.  
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Introduction 
 
Cyclometalated iridium complexes have received significant amount of interest in recent 
years.1-3 This is attributed to their rich photochemical properties, which results in their 
utility in areas such as cellular imaging, Organic Light Emitting Devices (OLEDs), 
potoredox catalysis, and others.4-9 Luminescence lifetimes reaching the microsecond 
regime, large Stokes’ shifts, and ease of spectral tuning of emission are the key favorable 
properties of these compounds. These desirable bio-physical properties result from the 
interplay of the iridium ion and its ligands. The large (5d) iridium ion carrying a relatively 
high charge (+3) together with the strong sigma donating character of the cyclometalating 
ligands ensure large ligand field.3 This results in lack of involvement of deactivating metal 
centered (MC) transitions in the photophysical properties of the complexes and in turn 
results in photophysics based around ligand centered, metal to ligand charge transfer 
(MLCT) centered, and other charge transfer transitions.10 Furthermore, the high spin-orbit 
coupling constant of the iridium center relaxes the forbidden nature of transitions between 
singlet and triplet states.11-13 This results in efficient intersystem crossing and emission 
that is phosphorescent in nature. Thus, the luminescence lifetimes of cyclometalated 
iridium complexes can reach the microsecond regime, which is significantly longer than 
for organic fluorophores yet much shorter than observed for phosphorescence from 
purely organic systems. Finally, the charge transfer nature of the phtophysical transitions 
results in localization of the HOMO and LUMO orbitals on different parts of the complexes. 
This leads to relatively facile tuning of the emission bands as independent modulation of 
the HOMO or LUMO orbitals is possible.14-15  
 The relatively long luminescence lifetimes and large Stokes’ shifts observed in 
cyclometalated iridium complexes are useful for bio-imaging purposes as they enable 
more facile separation of excitation and emission as well as separation of light emitted 
from the probe of the background auto-fluorescence.2, 16-17  
 Bis-cyclometalated iridium complexes is identified as the dominant structural class 
utilized in cellular imaging. This is mainly due to the facile synthesis of these complexes 
as well as their ability to carry a single positive charge which is assumed to be beneficial 
for cellular uptake during imaging experiment.13 The tris-cyclometalated iridium 
complexes that are frequently utilized in other applictations are considered to be superior 
to the bis-cyclometalated with respect to their photophysical properties but utilized to a 
much smaller extent. It appears that they are, in general, less efficiently internalized by 
cells due to being charge neutral.18-20  
 Our research group has recently published a report on two aminoalkyl substituted 
tris-cyclometalated iridium complexes derived from the archetypal complex [Ir(ppy)3] 
(Figure 1), which carry an aminoalkyl group on one of the 2-phenylpyridine ligands.21 The 
previously published complexes contained butyl and dodecyl chains on the amino group. 
These complexes have shown interesting photophysial properties, including a ratiometric 
response of their emission to pH, which was structure dependent. The possibility to utilize 
these complexes in cellular imaging has also been demonstrated. Derived form these 
promising results, we decided to synthesize further analogues of these compounds, which 
we report herein. The newly synthesized complexes bearing one and two 2-hydroxyethyl 
substituents on the amino group. The first one was synthesized as a direct analogue of 
the previously reported complexes containing simple alkyl groups while the latter was 
synthesized with reduced cytotoxicities in mind as it was observed for complexes where 
the secondary amino group is transformed into its tertiary amino analogue or a 
quarternary ammonium group.21-22  
  
 
 
 
Figure 1. Structures of tris-cyclometalted aminoalkyl iridium complexes reported by our 
group. 
 
 
Experimental 
 
General comments  
Unless otherwise stated, all commercial reagents were used as received. Silver 
trifluoromethanesulfonate, ethanolamine, diethanolamine, and sodium borohydride were 
purchased from Sigma Aldrich. Sodium cyanoborohydride, 2-phenylpyridine (ppy), 2-
ethoxyethanol, and silicagel were purchased from Merck. Butylamine, methyl iodide, and 
iridium(III)chloride trihydrate were purchased from Fisher. Dichlromethane, methanol, 
and triethyl amine were purchased from Carlo Erba. Sodium bicarbonate, anhydrous 
sodium sulphate, and trisodium phosphate were purchased from Univar. Acetonitrile and 
dimethyl sulfoxide were purchased from RCI. The precursor complex [Ir(ppy)2(fppy)] was 
synthesized as previously reported.21 1H and 13C NMR spectra were recorded on a Bruker 
Avance 400 MHz instrument operating at 400 MHz and 100 MHz for proton and carbon, 
respectively. Mass spectra were recorded with an Agilent technologies UHD Accurate-
Mass Q-TOF LC-MS instrument model 6540. UV-Visible spectra were recorded using 
Analytik Jena 210plus diode array spectrophotometer. Steady state emission spectra 
were recorded using Fluoromax-4 spectrofluorometer from Yvon Horiba. 
Phoshorescence lifetime measurements were performed on the DeltaFlexTM instrument 
equipped with a UV LED (ex = 372 nm). Cell viability was determined using the 
Chemometec NucleoCounter-3000 cell analyzer.  
 
 
Synthesis of fac-[Ir(ppy)2ppy-N-OH], (1) 
[Ir(ppy)2fppy] (0.22 mmol, 150 mg), ethanolamine (0.44 mmol, 27 µL), and triethylamine 
(0.22 mmol, 31 µL) were suspended in methanol:dichloromethane 1:1 mixture (10:10 mL). 
The mixture was heated at reflux under nitrogen for 10 h. The solution was left to cool to 
room temperature, and NaBH4 (0.44 mmol, 16.6 mg) was added. The reaction mixture 
was stirred at room temperature for 20 h. The solvent was removed under vacuum. The 
residue was dissolved in dichloromethane, dried over anhydrous sodium sulphate, and 
filtered. The solvent was completely removed under reduced pressure and the residue 
was dissolved in dichloromethane and purified by column chromatography on silica using 
gradient of methanol (up to 15%) in dichloromethane as the eluent. The pure product was 
isolated as an orange solid (0.10 mmol, 73.0 mg, 45 %). 1H NMR (400 MHz, CD3OD, )) 
2.81 (m, 2H), 3.62 (m, 2H), 3.78 (m, 2H), 6.65-6.76 (m, 4H), 6.83 (m, 3H), 6.89-6.98 (m, 
4H), 7.52 (m, 2H), 7.57 (m, 1H), 7.60-7.71 (m, 5H), 7.76 (d, J = 8.0 Hz, 1H), 7.95 (d, J = 
8.0 Hz, 1H), 8.00 (m, 2H).13C NMR (100 MHz, CD3OD, ) 49.92, 52.63, 58.24, 119.99, 
120.35, 121.01, 120.04, 121.75, 123.26, 123.32, 123.80, 125.15, 125.18, 125.56, 130.34, 
130.48, 133.92, 137.70, 137.74, 173.78, 173.85, 138.01, 139.20, 145.37, 145.38, 146.78, 
148.27, 148.39, 148.52, 161.56, 161.93, 163.70, 166.97, 167.81. HRMS (ES+) calcd. for 
C36H32IrN4O (729.2205); found (729.2228) [M+H]+. 
 
Synthesis of fac-[Ir(ppy)2ppy-N-(OH)2], (2) 
[Ir(ppy)2fppy]  (0.078 mmol, 53 mg), diethanolamine (0.12 mmol, 12 µL), and triethylamine 
(0.078 mmol, 11 µL) were suspended in methanol:dichloromethane 1:1 mixture (7:7 mL). 
The mixture was heated at reflux under nitrogen for 10 h. The solution was left to cool to 
room temperature, and NaBH4 (0.078 mmol, 3 mg) was added. The reaction mixture was 
stirred at room temperature for 20 h. The solvent was removed under vacuum. The 
residue was dissolved in dichloromethane, dried over anhydrous sodium sulphate, and 
filtered. The solvent was completely removed under reduced pressure and the residue 
was dissolved in dichloromethane and purified by column chromatography on silica using 
gradient of methanol (up to 15%) in dichloromethane as the eluent. The pure product was 
isolated as an orange solid (0.040 mmol, 30.8 mg, 51 %). 1H NMR (400 MHz, CD3OD, )) 
3.08 (m, 4H), 3.69 (m, 4H), 4.09 (s, 2H), 6.63 (dd, J = 7.6 Hz, J = 1.2 Hz, 1H), 6.68 (dd, 
J = 7.2 Hz, J = 1.2 Hz, 1H), 6.73 (m, 2H), 6.78 (d, J = 4.0 Hz, 1H), 6.85 (m, 2H), 6.97 (m, 
3H), 7.04 (m, 1H), 7.57 (m, 1H), 7.60 (m, 1H), 7.63 (m, 1H), 7.71 (m, 5H), 7.80 (d, J = 8.0 
Hz, 1H), 8.01 (m, 2H), 8.06 (d, J = 8.0 Hz, 1H).13C NMR (100 MHz, CD3OD, ) 55.50, 
56.55, 58.43, 119.99, 120.07, 120.60, 121.08, 121.15, 123.32, 123.45, 123.57, 124.18, 
125.20, 125.25, 125.52, 130.43, 130.62, 137.67, 137.77, 137.86, 137.92, 137.93, 140.92, 
145.36, 148.38, 145.45, 148.73, 161.35, 161.81, 163.95, 166.66, 167.73, 167.81.  HRMS 
(ES+) calcd. for C38H36IrN4O2 (773.2468); found (773.2470) [M+H]+. 
 
Photochemical measurements 
Unless otherwise stated, stock solutions of iridium complexes (0.5 mM) were prepared in 
DMSO. They were then diluted to their desired concentration (typically 10 M) with the 
appropriate solvent. The measurements were performed in quartz cuvettes of 1 cm path 
length. Degassing of the samples for lifetime measurements have been achieved by 
bubbling nitrogen gas through them for 10 minutes in order to eliminate the presence of 
oxygen.  
 Luminescence quantum yields were determined using fac-[Ir(ppy)3] in degassed 
dichloromethane solution as the standard, for which lum = 0.89.23 The solutions for this 
measurement were degassed by four cycles of freeze-pump-thaw.  
Luminescence lifetimes of the complexes were measured by time-correlated-
single-photon-counting (TCSPC) using a laser diode (372 nm) as the excitation source.  
The estimated error in the lifetimes is 10%. 
 
DFT Calculations 
Calculations were carried out with the Gaussian09 software package at the DFT level, 
using the hybrid functional B3LYP and the double-zeta basis set LANL2DZ.24 The 
calculations were carried out for a vacuum environment as well dichloromethane (ε = 
8.93) using the polarizable continuum model. The molecular orbitals were visualized 
using the Gabeit program package.25 
 
Cell Culture 
A detailed investigation of the cellular behaviour of each complex was conducted using 
mouse skin fibroblasts (NIH-3T3) and human prostate adenocarcinoma (PC3) cell lines 
using fluorescence and laser scanning confocal microscopy. Cells were maintained in 
exponential growth as monolayers in F-12/DMEM (Dulbecco’s Modified Eagle Medium) 
1:1 that was supplemented with 10% foetal bovine serum (FBS). Cells were grown in 75 
cm2 plastic culture flasks, with no prior surface treatment. Cultures were incubated at 37 
°C, 20% average humidity and 5% (v/v) CO2. Cells were harvested by treatment with 
0.25% (v/v) trypsin solution for 5 min at 37 ºC. Cell suspensions were pelleted by 
centrifugation at 1000 rpm for 3 min, and were re-suspended by repeated aspiration with 
a sterile plastic pipette. Cells destined for Microscopy experiments were seeded in 12-
well plates on 13mm 0.170mm thick standard glass cover-slips or un-treated iBibi 100 uL 
live cell channels and allowed to grow to 40% – 60% confluence, at 37 ºC in 5% CO2. At 
this stage, the medium was replaced  and cells were treated with complexes and co-
stains as appropriate. For imaging DMEM media (10% FBS) lacking phenol red (live cell 
media) was used from this point onwards. Following incubation, the cover-slips were 
washed with live cell media, mounted on slides and the edges sealed with colourless, 
quick-dry nail varnish to prevent drying out of the sample. 
 Cell toxicity measurements were run using a ChemoMetec A/S 
NucleoCounter3000-Flexicyte instrument with Via1-cassette cell viability cartridge (using 
the cell stain Acridine Orange for cell detection, and the nucleic acid stain DAPI for 
detecting non-viable cells). The experiments were done in triplicate. In cellular uptake 
studies cells were seeded in 6-well plates and allowed to grow to 80% – 100% confluence, 
at 37 ºC in 5% CO2. At this stage, the medium was replaced with media containing 
targeted complexes as detailed above and total cellular Iridium was determined using 
ICP-MS, inductively coupled plasma mass spectrometry by Dr. C. Ottley in the 
Department of Earth Sciences at Durham University.  
 
Steady state fluorescence microscopy 
Steady state fluorescence images were recorded using a PhMoNa26 enhanced Leica SP5 
II LSCM confocal microscope equipped with a HCX PL APO 63x/1.40 NA LambdaBlue 
Oil immersion objective. Data were collected using 2.5x digital magnification at 400 
Hz/line scan speed (4 line average, bidirectional scanning) at 355 nm (3rd harmonic 
NdYAG laser) with 3 mW laser power (80 nJ/voxel). In order to achieve excitation with 
maximal probe emission, the microscope was equipped with a triple channel imaging 
detector, comprising a conventional PMT systems and two HyD hybrid avalanche 
photodiode detector. The latter part of the detection system, when operated in the 
BrightRed mode, is capable of improving imaging sensitivity by 25%, reducing signal to 
noise by a factor of 5. Frame size was determined at 2048 x 2048 pixel, with 0.6 airy disc 
unit determining the applied pinhole diameter rendering on voxel to be corresponding to 
24.02 x 24.02 nm (frame size 49.16 x 49.16 μm) with a section thickness of 380 nm. A 
HeNe or Ar ion laser was used when commercially available organelle-specific stains (e.g. 
MitoTrackerRedTM) were used to corroborate cellular compartmentalization. Spectral 
imaging on this Leica system is possible with the xyλ-scan function, using the smallest 
allowed spectral band-pass (5nm) and step-size (3nm) settings. However, much 
improved spectral imaging in cells was achieved using a custom built microscope 
(modified Zeiss Axiovert 200M), using a Zeiss APOCHROMAT  63x/1.40 NA objective 
combined with a low voltage (5 V) 365 nm pulsed UV LED focused, collimated excitation 
source (1.2W). For rapid spectral acquisition the microscope was equipped at the X1 port 
with a Peltier cooled 2D-CCD detector (Ocean Optics, MayaPro2000) used in an inverse 
100 Hz time gated sequence. The spectrum was recorded from 400-800 nm with a 
resolution of 0.24 nm and the final spectrum was acquired using an averaged 10,000 
scan duty cycle. Probe lifetimes were measured on the same microscope platform using 
a novel cooled PMT detector (Hamamatsu H7155) interchangeable on the X1 port, with 
the application of pre-selected interference filters matched to as selected in live cell LSCM 
experiments. Both the control and detection algorithm were written in LabView2013, 
where probe lifetime was determined by using a single exponential fitting algorithm to the 
monitored signal intensity decay.  
 
 
 
Scheme 1. Synthesis of complexes 1 and 2 
 
Results and discussion  
Synthesis 
 
The complexes have been synthesized using slight modifications of the procedures from 
our previous report. In short, the complexes were prepared in three steps. The first step 
is the synthesis of a chloride bridged iridium dimer from iridium chloride and 2-phenyl 
pyridine using the Nonoyama reaction. This was followed by the transformation of the 
dimer using 4-(pyridine-2-yl)benzaldehyde into a monomeric complex [Ir(ppy)2fppy]. 
Finally, the novel aminoalkyl iridium complexes were synthesized in a reductive amination 
reaction with ethanolamine and diethanolamine to give complexes 1 and 2, respectively 
(Scheme 1). The complexes were characterized by 1H-NMR, 13C-NMR, and HRMS.   
 
Photophysical properties 
The UV-vis absorption and PL emission spectra of complexes 1 and 2 recorded in 
dichloromethane exhibit the same features. The absorption spectra can be divided into 
three key regions. Firstly, the strong absorption observed below 320 nm and centered 
around 280 nm can be assigned to allowed  to  transitions in the ligands (Figure 2). 
The weaker absorption band centered at 390 nm corresponds to singlet metal to ligand 
charge-transfer transitions (1MLCT) while the weak tail extending beyond 450 nm 
originates from forbidden triplet metal to ligand charge-transfer transition (3MLCT). The 
steady state emission spectra of both complexes in dichlomethane exhibit a single peak 
with a maximum at 513 nm (Figure 2). The photophysical properties are further 
summarized in Table 1.  
 
Table 1. Photophysical properties of complexes 1 and 2 
 
 1 2 
Absorption (max/nm)a 283, 376 283, 380  
Emission (max/nm)a 513 513 
Quantum Yield (lum)a 0.91 0.98 
Lifetime (ns)a 1422 (51) 1301 (44) 
Lifetime (ns)c 322 176 
a) dichloromethane, b) dimethylsulfoxide, c) tetrahydrofuran  
 
The quantum yields observed for both complexes are on the order of 40% and are similar 
to the parent complex and our previously reported structures. Same conclusion can be 
drawn for the luminescence lifetime. Complex 1 exhibits lifetimes of 41 ns and 1.42 s in 
aerated and degassed dichloromethane solutions, respectively, while complex 2 exhibits 
lifetimes of 44 ns and 1.30 s under these conditions. The similarity of the photophysical 
properties of complexes 1 and 2 with each other and with our previously reported 
compounds were further demonstrated by the results of Density Functional Theory (DFT) 
calculations carried out using the polarizable continuum model for dichloromethane 
solution at the B3LYP/LANL2DZ level of theory. The results of this calculation are shown 
in Figure 3, which demonstrates that the HOMO orbital for both complexes is mainly 
located on the iridium atom while the LUMO orbital is predominantly located on the 
cyclometalating ligand carrying the aminoalkyl substituent. This is consistent with the 
expected MLCT nature of the electronic transitions in this type of cyclometalated iridium 
complexes. In addition, the calculated energy difference between these orbitals is 3.50 
eV, which is consistent with the observed absorption spectrum. Furthermore TD-DFT 
calculations have been carried out to model the UV-Vis spectra of complexes 1 and 2. 
Comparison of the experimental and calculated spectra can be seen in SI Figure 7, which 
shows a good match between the observed and simulated data.  
  
 
 
 
Figure 2. Normalized absorption (dashed) and emission (full) spectra of complexes 1 
(red) and 2 (blue) (10 M)recorded in dichloromethane (ex = 390 nm) 
 
 
Figure 3. The HOMO and LUMO orbitals of complexes 1 (left) and 2 (right) calculated in 
dichloromethane. 
 
While the photophysical properties of complexes 1 and 2 are very similar in 
dichloromethane, they exhibit significant differences in aqueous media. Complex 1 shows 
a single emission peak with a maximum around 530 nm, complex 2 displays a structured 
emission spectrum with a maximum at 580 nm and a shoulder around 520 nm (Figure 
4). The emission spectrum of this class of complexes depends on the structure of the 
group attached to the nitrogen atom has been reported in our previous work where butyl 
and dodecyl chains have been used.21 The appearance of the emission peak at 580 nm 
was attributed to aggregation of the complex in solution. This phenomenon was in fact 
the driving force behind the design of complexes 1 and 2 where the originally used alkyl 
chain was replaced by a more hydrophilic ethylene hydroxyl unit, expected to result in a 
more hydrophilic complex, which would be less likely to aggregate. This goal appears to 
have been achieved for complex 1. Surprisingly Complex 2, on the other hand appears 
to be even more prone to aggregation that the previously reported complex containing a 
butyl chain as it exhibits the emission peak at 580 nm, which was absent in the case of 
the butyl chain containing complex. 
 
 
 
Figure 4. Normalized absorption and emission spectra of complexes 1 (red) and 2 (blue) 
(10 M)recorded in water (ex = 390 nm) 
 
The decreased propensity of complex 1 to aggregate is demonstrated by its 
monoexponetial excited state decay in aqueous solution, where, on account of 
aggregation, the previously reported complexes, as well as complex 2 showed 
multiexponential decays (SI Figure 8). This is further demonstrated by the photophysical 
behavior in phosphate buffer solutions. In this case, at pH 7.5, the previously reported 
butyl complex (Figure 1) exhibited the presence of the emission peak at 580 nm assigned 
to aggregated form, as is also seen in the case of complex 2. On the other hand, complex 
1 still only contains a single emission peak at 530 nm (SI Figure 9).  
The similarity of complex 2 to the parent butyl analogue and decreased propensity 
to aggregate for complex 1 is also shown in the plot of the ratio of emission intensity at 
580 nm to emission intensity at 530 nm measured in phosphate buffer for the pH range 
5.5 to 10.0 (Figure 5). It has been established, that for complex 1 this ratio at pH 5.5 has 
the value of 0.61 while for complex 2 the ratio value is 1.10. At pH 10.0, the emission 
intensity ratio values are 1.42 and 2.98 for complexes 1 and 2, respectively. The 
corresponding intensity ratio values for the butyl complex were 0.83 and 5.03 at pH 5.5 
and 10.0 respectively (SI Figure 10). This confirms, that the complexes are much more 
prone to aggregate at higher pH values as they exhibit higher values of the intensity ratio, 
which is understandable as at higher pH values the amino group become deprotonated 
making aggregation more favorable. Thus, at pH 10.0 even complex 2 exhibits decreased 
propensity to aggregate than the butyl complex, as was expected. We have previously 
discussed that both the hydrophilicity/hydrophobicity of the chains attached to the amino 
group and its protonation state affect the propensity to aggregate. The interplay of these 
factors is the likely explanation for the higher than expected propensity to aggregate for 
complex 2. This is because diethanolamine, which it is based on, is the most hydrophilic 
of the three amines but also least basic (SI Table 1), meaning that at any given pH it 
contains the highest proportion of the molecules in the aggregation prone free base form.  
 
 
 
Figure 5. Plot of the ratio of emission intensity at 580 nm and 530 nm for complexes 1 
and 2 versus pH  
 
Cellular Experiments 
Complexes 1 and 2 have been synthesized as part of our ongoing effort to investigate 
how the nature of aminoalkyl structure in these tris-cyclometalated iridium complexes 
affects their bio-compatibility and performance as potential stains for fluorescence 
microscopy. We have recently published a report on a quarternary ammonium salt of the 
butyl substituted complex, in addition to the previously mentioned report on the 
complexes bearing the butyl and dodecyl chain.21-22 Our previously reported complexes 
have displayed lysosomal localization. However, the quarternary ammonium complex 
stood out in terms of its significantly lower cytotoxicity. Figure 6 shows the plot of viability 
of NIH-3T3 cells incubated with complexes 1 and 2 for 24h. It can be seen, that complex 
1 shows IC50 below 5 M, which is similar to what was observed for the alkyl complexes. 
On the other hand, complex 2 shows significantly lower cytotoxicity with IC50 value on the 
order of 50 M. Complex 2 is, in this respect, more similar to the quarternary ammonium 
complex, which has also shown lower cytoxicity than the simple aminoalkyl complexes.  
 
 
 
Figure 6. Plot of cellular viability of NIH-3T3 cells versus concentration for 1 and 2 (24 h)  
 
ICP-MS analyses, which were carried out on cell lysates after incubation with complexes 
1 and 2 do indicate that complex 1 exhibits higher intracellular concentration than complex 
2, which could, in part, provide explanation for the decreased cytotoxicity of complex 2.  
 Figure 7 and Figure 8 show the results of fluorescence (LSCM) imaging 
experiments with complexes 1 and 2, respectively, in NIH-3T3 cells. The cellular 
localization of the two complexes is compared to that of lysotracter red. Images for 
complex 1 were acquired after 1 h incubation with 2 M solution of the complex. The 
lower cytotoxicity of complex 2 allowed incubation with a 5 M solution of the complex for 
two 2h, which resulted in better quality images. It can be seen, that complex 2 (Figure 8) 
exhibits lysosomal localization, analogous to that observed for our previously reported 
complexes. On the other hand, while there is some degree of overlap between the images 
obtained with complex 1 (Figure 7) and lysotracker red, complex 1 does show a more 
diffuse emission throughout the cytosol.   
 
 
 
Figure 7. LSCM microscopy images of NIH-3T3 cells obtained with complex 1 (ex 355 
nm, em 450-650 nm) (a), lysotacker red (ex 543 nm HeNe laser, em 600-650 nm) (b). 
Panel c shows the RGB overlay of panels and a b; P = 0.68, while panel d is the birghtfield 
image. (Scale bar: 20 m) 
 
 
 
Figure 8. LSCM microscopy images of NIH-3T3 cells obtained with complex 1 (ex 355 
nm, em 450-650 nm) (a), lysotacker red (ex 543 nm HeNe laser, em 600-650 nm) (b). 
Panel c shows the RGB overlay of panels and a b; P = 0.74, while panel d is the birghtfield 
image. (Scale bar: 20 m) 
a) b) 
c) d) 
a) b) 
c) d) 
Conclusions 
In conclusion, two novel tris-cyclometalated iridum complexes have been synthesized 
and investigated. These complexes are analogues of our previously reported aminoalkyl 
complexes containing one (1) and two (2) hydroxylethyl groups on the nitrogen atoms. 
The photophysical properties of complexes 1 and 2 in organic solvent are similar to the 
parent complex fac-[Ir(ppy)3] and our previously reported aminoalkyl complexes. In 
aqueous media, complex 1 exhibits the properties expected from the inclusion of the 
hydrophilic group on the nitrogen atom as evidenced by its decreased tendency to 
aggregate. Complex 2 shows properties that are intermediate between those of complex 
1 and the previously reported complex containing a butyl chain, which is likely due to a 
lower basicity. Cellular imaging was achieved with both complexes, however, complex 2 
is more promising in this respect given its lower cytotoxicity and better defined cellular 
localization. 
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- Two novel tris-cyclometalated iridium complex containing aminoalkyl group with 
hydroxyethyl chains have been synthesized 
- The photophysical properties of the iridium complexes in aqueous solution depend on 
the number of hydroxyl ethyl chains bound to the nitrogen atom 
- The synthesized iridium complexes can be used as stains for fluorescence microscopy in 
live NIH-3T3 cells 
 
 
 
 
 
 
